$VTEX

Gomes Andre Spolidoro Ferreira sold $12K of VTEX (indirect holdings)

Gomes Andre Spolidoro Ferreira (Chief Strategy Officer) sold 3,000 indirectly-held shares of VTEX (VTEX) at $4.04 on 2026-07-16 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Gomes Andre Spolidoro Ferreira
Published Jul 17, 2026, 9:49 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 17, 2026, 9:50 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$VTEX
Neutral
high confidence
Mentioned
$VTEX
Relevance
2/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VTEXNeutralLow
01

Why it matters

The disclosure updates insider trading records but does not introduce new company-specific catalysts like earnings, guidance, contracts, or regulatory actions.

02

Market read

Traders may note the planned insider sale for positioning, but it is unlikely to drive a fundamental repricing.

03

What to watch

The transaction is indirect and under a pre-arranged plan; without additional context (e.g., total insider activity trend), the signal is weak.

Relevance 2/10Novelty 3/10Timing: Filed after-hours on 2026-07-17, covering a sale dated 2026-07-16.

Background

The article is an SEC Form 4 insider transaction disclosure for VTEX, reported as an open-market sale under a Rule 10b5-1 plan.

Company-level read

Ticker impact

$VTEXNeutralHigh confidence
Context

VTEX Form 4 shows CSO Gomes Andre Spolidoro Ferreira sold 3,000 shares at $4.0400 on a 10b5-1 plan, worth $12,120.

Expected impact

Likely minimal impact; any effect is more about liquidity/positioning than company news.

Evidence & confidence

The filing is an SEC Form 4 insider transaction, but it specifies a pre-arranged 10b5-1 plan and a relatively small dollar value, providing no new operating or regulatory information.

Market effects

No clear sector read-through from a small, planned insider sale.

None indicated.

None indicated.

Counterpoint

Even with 10b5-1, repeated insider selling can coincide with internal expectations of limited upside, so some traders may still fade strength.

Key entities

  • VTEX

    Company whose insider transaction is disclosed on SEC Form 4.

  • Gomes Andre Spolidoro Ferreira

    Chief Strategy Officer reporting an indirect open-market sale of 3,000 shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$VTEXMed

VTEX (VTEX) Just Turned A Profit Corner, But Growth Is Slowing

VTEX (NYSE:VTEX) reported Q2 2026 results showing improved profitability with non-GAAP income from operations up 62.4% YoY to $13.8M, and free cash flow up 79.1% to $12.7M. However, revenue growth slowed to 1.3% YoY on an FX-neutral basis, with management expecting flat growth for Q3. The company repurchased 6.2M shares for $23.2M during the quarter.

$VTEXMedAI 8/10

VTEX (VTEX) Q2 2026 Earnings Call Transcript

VTEX reported Q2 2026 results in an earnings call. GMV was $5.7B, up 7% FX-neutral. Subscription revenue was $63.8M, up 1.3% FX-neutral. Non-GAAP operating income rose 62% to $13.8M, with a 21.4% margin. Free cash flow was $12.7M, up 79%. Q3 guidance calls for flat FX-neutral subscription growth.

$VTEXMedAI 8/10

VTEX Q2 Earnings Call Highlights

VTEX (NYSE:VTEX) reported Q2 margin and cash flow improvement and guided for Q3 and full-year low-single-digit FX-neutral subscription revenue growth and low-20% non-GAAP operating and free cash flow margins. Q2 non-GAAP subscription gross margin rose to 81.8%. Free cash flow rose 79% to $12.7M. VTEX repurchased 6.2M shares at $3.76.

$VTEXMed

VTEX (VTEX): Financial results for Q2 2026

VTEX (VTEX) furnished an SEC Form 6-K — earnings release. VTEX Reports Second Quarter 2026 Financial Results Subscription revenue grew 11.4% (+1.3% FXN), with GMV up 17.8% (+7.0% FXN) Non-GAAP income from operations increased 62.4% to US$13.8 million, reaching a 21.4% margin Free cash flow increased 79.1% to US$12.7 million, reaching a